• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于嵌合瓜氨酸化肽的多重分析方法的开发,作为类风湿关节炎诊断概念验证。

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis.

机构信息

Unit of Synthesis and Biomedical Applications of Peptides, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.

Arthritis Unit, Hospital Clinic, Barcelona, Spain.

出版信息

PLoS One. 2019 May 2;14(5):e0215927. doi: 10.1371/journal.pone.0215927. eCollection 2019.

DOI:10.1371/journal.pone.0215927
PMID:31048864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6497438/
Abstract

Anti-citrullinated peptide/protein antibodies (ACPAs) are the most specific serological biomarkers for rheumatoid arthritis (RA). They have both diagnostic and prognostic value, and are related to more aggressive joint disease in RA. However, a single biomarker cannot differentiate RA subtypes. So, simultaneous analysis of target citrullinated peptides, using a multiplex array based on chimeric peptides composed of several domains of human proteins, could be useful. In this work, eight chimeric peptides and the corresponding native arginine-containing control peptides were obtained by solid-phase peptide synthesis. The study included RA and psoriatic arthritis (PsA) patients attending the Rheumatology Unit of the Hospital Clinic in Barcelona, as well as healthy blood donors (BD) at the same hospital. Our main aim was to explore the diagnostic value of the novel multiplex array compared to a commercial ELISA-based ACPA assay in a serum-saving way. Using the combination of the eight chimeric peptide antigens in the multiplex array, 61.4% of the RA cohort were positive for 3 or more peptides; while, the healthy BD and PsA cohorts did not show any reactivity with the tested peptides. These results indicate that we have developed a highly specific multiplex assay based of chimeric citrullinated peptides derived from filaggrin, fibrin, vimentin and human enolase proteins for the detection of ACPAs in a serum-saving way.

摘要

抗瓜氨酸化肽/蛋白抗体(ACPAs)是类风湿关节炎(RA)最特异的血清学生物标志物。它们具有诊断和预后价值,与 RA 更具侵袭性的关节疾病有关。然而,单一的生物标志物无法区分 RA 亚型。因此,同时分析靶向瓜氨酸化肽,使用基于由几种人蛋白域组成的嵌合肽的多重阵列可能是有用的。在这项工作中,通过固相肽合成获得了 8 个嵌合肽和相应的天然含精氨酸对照肽。该研究包括在巴塞罗那 Clinic 医院风湿病科就诊的 RA 和银屑病关节炎(PsA)患者,以及来自同一医院的健康献血者(BD)。我们的主要目的是探索新型多重阵列与基于商业 ELISA 的 ACPA 检测在节省血清的方式下的诊断价值。使用多重阵列中的 8 种嵌合肽抗原的组合,61.4%的 RA 队列对 3 种或更多肽呈阳性;而健康的 BD 和 PsA 队列则没有对测试肽表现出任何反应性。这些结果表明,我们已经开发了一种基于源自丝聚蛋白、纤维蛋白、波形蛋白和人烯醇化酶蛋白的嵌合瓜氨酸化肽的高度特异的多重分析,以节省血清的方式检测 ACPAs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/d94be02bf778/pone.0215927.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/e55929c22365/pone.0215927.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/5f2d8ee25e01/pone.0215927.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/6370152785ea/pone.0215927.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/8fc6d03b8d15/pone.0215927.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/d94be02bf778/pone.0215927.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/e55929c22365/pone.0215927.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/5f2d8ee25e01/pone.0215927.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/6370152785ea/pone.0215927.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/8fc6d03b8d15/pone.0215927.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6497438/d94be02bf778/pone.0215927.g005.jpg

相似文献

1
Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis.基于嵌合瓜氨酸化肽的多重分析方法的开发,作为类风湿关节炎诊断概念验证。
PLoS One. 2019 May 2;14(5):e0215927. doi: 10.1371/journal.pone.0215927. eCollection 2019.
2
Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays.抗嵌合瓜氨酸合成肽抗体与 CCP3/CCP3.1 检测在诊断和预后中的对比研究。
Clin Chem Lab Med. 2018 Jan 26;56(2):285-293. doi: 10.1515/cclm-2017-0264.
3
An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.一项关于抗环瓜氨酸肽(ACPA)多重检测在早期类风湿关节炎环境中的附加值的调查。
Arthritis Res Ther. 2015 Oct 5;17:276. doi: 10.1186/s13075-015-0786-z.
4
Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis.循环瓜氨酸化抗原和抗环单克隆瓜氨酸肽抗体在类风湿关节炎中的致病作用。
Front Immunol. 2021 Jun 30;12:692242. doi: 10.3389/fimmu.2021.692242. eCollection 2021.
5
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.抗突变型瓜氨酸波形蛋白与抗环瓜氨酸肽和抗病毒瓜氨酸化肽 2 抗体在类风湿关节炎中的诊断价值:一项意大利多中心研究及文献复习。
Autoimmun Rev. 2012 Sep;11(11):815-20. doi: 10.1016/j.autrev.2012.02.015. Epub 2012 Feb 27.
6
The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis.类风湿关节炎中对环瓜氨酸化胶原蛋白 II 肽的自身抗体反应。
Rheumatology (Oxford). 2019 Sep 1;58(9):1623-1633. doi: 10.1093/rheumatology/kez073.
7
The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis.用嵌合波形蛋白瓜氨酸化肽进行类风湿关节炎的诊断。
J Med Chem. 2011 Nov 10;54(21):7486-92. doi: 10.1021/jm200563u. Epub 2011 Oct 7.
8
The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.合成肽在类风湿关节炎中用于检测抗瓜氨酸化蛋白抗体的应用。
J Immunol Methods. 2018 Mar;454:6-14. doi: 10.1016/j.jim.2017.11.004. Epub 2017 Nov 8.
9
Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.基于多重芯片检测法检测抗瓜氨酸化肽自身抗体的验证
Arthritis Res Ther. 2012 Oct 1;14(5):R201. doi: 10.1186/ar4039.
10
Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.已确诊类风湿关节炎的抗瓜氨酸化肽抗体谱分析。
Joint Bone Spine. 2018 Jul;85(4):441-445. doi: 10.1016/j.jbspin.2017.07.009. Epub 2017 Aug 5.

引用本文的文献

1
Multi-target drug discovery for rheumatoid arthritis: a comprehensive computational approach using bioactive compounds.类风湿性关节炎的多靶点药物发现:一种使用生物活性化合物的综合计算方法。
Sci Rep. 2025 Jul 28;15(1):27516. doi: 10.1038/s41598-025-12666-4.
2
Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.基于具有三种翻译后修饰(瓜氨酸化、同型瓜氨酸化和乙酰化)的烯醇化酶肽抗原(CEP-1)的新型嵌合肽,用于确定类风湿关节炎的诊断和严重程度。
Int J Mol Sci. 2024 Oct 3;25(19):10654. doi: 10.3390/ijms251910654.
3

本文引用的文献

1
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.抗瓜氨酸化蛋白/肽抗体多重检测定义了一组具有独特遗传和环境决定因素的 ACPA 阳性类风湿关节炎患者。
Ann Rheum Dis. 2018 Feb;77(2):203-211. doi: 10.1136/annrheumdis-2017-211782. Epub 2017 Oct 25.
2
Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays.抗嵌合瓜氨酸合成肽抗体与 CCP3/CCP3.1 检测在诊断和预后中的对比研究。
Clin Chem Lab Med. 2018 Jan 26;56(2):285-293. doi: 10.1515/cclm-2017-0264.
3
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis.
翻译后修饰在自身免疫中的意义,重点探讨瓜氨酸化、高瓜氨酸化和乙酰化在类风湿关节炎发病机制、诊断及预后中的作用
Int J Mol Sci. 2022 Dec 13;23(24):15803. doi: 10.3390/ijms232415803.
4
Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients.具有多种翻译后修饰的肽作为严重类风湿关节炎患者的抗原靶点。
Int J Mol Sci. 2021 Dec 10;22(24):13290. doi: 10.3390/ijms222413290.
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.
超越瓜氨酸化:类风湿关节炎中的其他翻译后蛋白质修饰。
Nat Rev Rheumatol. 2017 Jun;13(6):331-339. doi: 10.1038/nrrheum.2017.15. Epub 2017 Mar 9.
4
An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.一项关于抗环瓜氨酸肽(ACPA)多重检测在早期类风湿关节炎环境中的附加值的调查。
Arthritis Res Ther. 2015 Oct 5;17:276. doi: 10.1186/s13075-015-0786-z.
5
Anti-citrullinated peptide antibodies in Sudanese patients with Leishmania donovani infection exhibit reactivity not dependent on citrullination.苏丹杜氏利什曼原虫感染患者体内的抗瓜氨酸化肽抗体表现出不依赖瓜氨酸化的反应性。
Scand J Immunol. 2015 Mar;81(3):201-8. doi: 10.1111/sji.12265.
6
Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.类风湿关节炎中的丙二醛-乙醛加合物和抗丙二醛-乙醛抗体。
Arthritis Rheumatol. 2015 Mar;67(3):645-55. doi: 10.1002/art.38969.
7
Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.抗环瓜氨酸肽阴性类风湿关节炎亚组中抗瓜氨酸化蛋白抗体反应性的鉴定:与吸烟及HLA - DRB1“共同表位”等位基因的关联
Ann Rheum Dis. 2015 Mar;74(3):579-86. doi: 10.1136/annrheumdis-2013-203915. Epub 2013 Dec 2.
8
Citrullinated peptides in the diagnosis of rheumatoid arthritis.瓜氨酸化肽在类风湿关节炎诊断中的应用。
Curr Top Med Chem. 2013;13(6):743-51. doi: 10.2174/1568026611313060007.
9
Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.基于多重芯片检测法检测抗瓜氨酸化肽自身抗体的验证
Arthritis Res Ther. 2012 Oct 1;14(5):R201. doi: 10.1186/ar4039.
10
The pathogenesis of rheumatoid arthritis.类风湿关节炎的发病机制。
N Engl J Med. 2011 Dec 8;365(23):2205-19. doi: 10.1056/NEJMra1004965.